Behavioural Pharmacology

Top Research Topics at Behavioural Pharmacology?

The foci of the journal are Pharmacology, Internal medicine, Endocrinology, Neuroscience and Anesthesia. It focuses on Pharmacology but the discussions also offer insight into other areas such as Agonist, Receptor, NMDA receptor, Antagonist and Dopamine. Behavioural Pharmacology is mostly focused on Endocrinology, specifically Amphetamine.

The journal encompasses presentations on Anesthesia, specifically Morphine and Saline.

• Pharmacology (35.60%)
• Internal medicine (21.59%)
• Endocrinology (20.91%)

What are the most cited papers published in the journal?

• The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. (695 citations)
• A review of delay-discounting research with humans: relations to drug use and gambling. (567 citations)
• Tolerance and sensitization to the behavioral effects of drugs. (553 citations)

Research areas of the most cited articles at Behavioural Pharmacology:

The published articles primarily tackle Pharmacology, Internal medicine, Endocrinology, Neuroscience and Receptor. The studies on Pharmacology discussed at the journal papers can also contribute to research in the domains of Agonist, Amphetamine, Dopamine, Antagonist and Cannabinoid. The Internal medicine research presented in the journal articles focuses mostly on Anesthesia and, on occasion, topics in Nicotine.

What topics the last edition of the journal is best known for?

• Internal medicine
• Gene
• Pharmacology

The previous edition focused in particular on these issues:

The journal covers a variety of subjects, including Pharmacology, Endocrinology, Internal medicine, Agonist and Opioid. Topics in Pharmacology were tackled in line with various other fields like Nociception, Behavioural despair test, Antidepressant, Potency and Stimulus control. The Endocrinology works featured in it incorporate elements from Prefrontal cortex, Antagonist and Anxiety.

The studies in Internal medicine featured incorporate elements of Olanzapine and Protein kinase A. In Behavioural Pharmacology, Serotonin, Dopamine receptor and Cognitive flexibility are investigated in conjunction with one another to address concerns in Agonist research. Issues in Opioid were discussed, taking into consideration concepts from other disciplines like Morphine, Anesthesia and Analgesic.

The most cited articles from the last journal are:

• 'Reinventing the wheel' to advance the development of pain therapeutics. (6 citations)
• Glucagon-like peptide-1 receptor agonist, exendin-4, reduces reinstatement of heroin-seeking behavior in rats. (4 citations)
• Combined nicotine and ethanol age-dependently alter neural and behavioral responses in male rats. (3 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Behavioural Pharmacology (based on the number of publications) are:

• Paul Willner (67 papers) published 3 papers at the last edition, 1 more than at the previous edition,
• Louk J. M. J. Vanderschuren (44 papers) published 4 papers at the last edition, 2 more than at the previous edition,
• Jack Bergman (43 papers) published 2 papers at the last edition the same number as at the previous edition,
• Bart A. Ellenbroek (37 papers) absent at the last edition,
• Ian P. Stolerman (29 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Behavioural Pharmacology (based on the number of publications) are:

• Virginia Commonwealth University (44 papers) published 2 papers at the last edition the same number as at the previous edition,
• University of Texas Health Science Center at San Antonio (42 papers) published 1 paper at the last edition the same number as at the previous edition,
• National Institutes of Health (39 papers) published 2 papers at the last edition,
• National Institute on Drug Abuse (35 papers) published 1 paper at the last edition, 1 less than at the previous edition,
• University of Chicago (34 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 14.08% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 13.11% were posted by at least one author from the top 10 institutions publishing in the journal. Another 4.92% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 18.03% of all publications and 63.93% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Behavioural Pharmacology

While the field of Behavioural Pharmacology can seem overwhelming due to its broad scope and intricate concepts, it is a rewarding and expansive career. Opportunities in this field include roles in academia, pharmaceutical companies, medical writing, and healthcare. One exciting career path in this field is a role as a Speech Language Pathologist. A Speech-Language Pathologist in the context of Behavioural Pharmacology can analyze the neurological impact of drugs on speech patterns and abilities. This can be vital in building individualized patient treatment plans that cater to their neurological and pharmacological needs.

One intriguing aspect of pursuing this career as a Speech-Language Pathologist is the ability to work in dynamic locations. For example, those interested in working in the scenic state of Hawaii can explore our guide on how to become a speech therapist in Hawaii. The guide offers insights on local requirements and tips on making a successful career transition. This profession not only offers a sense of purpose but also enables you to make a real difference in people's lives while contributing to advancements in Behavioural Pharmacology.